186 related articles for article (PubMed ID: 36127323)
1. Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.
Blümel L; Qin N; Berlandi J; Paisana E; Cascão R; Custódia C; Pauck D; Picard D; Langini M; Stühler K; Meyer FD; Göbbels S; Malzkorn B; Liebau MC; Barata JT; Jeibmann A; Kerl K; Erkek S; Kool M; Pfister SM; Johann PD; Frühwald MC; Borkhardt A; Reifenberger G; Faria CC; Fischer U; Hasselblatt M; Bartl J; Remke M
Cell Death Dis; 2022 Sep; 13(9):806. PubMed ID: 36127323
[TBL] [Abstract][Full Text] [Related]
2. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
3. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
Bookhout C; Bouldin TW; Ellison DW
Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
[TBL] [Abstract][Full Text] [Related]
4. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
5. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
[TBL] [Abstract][Full Text] [Related]
6. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
Johann PD; Altendorf L; Efremova EM; Holsten T; Steinbügl M; Nemes K; Eckhardt A; Kresbach C; Bockmayr M; Koch A; Haberler C; Antonelli M; DeSisto J; Schuhmann MU; Hauser P; Siebert R; Bens S; Kool M; Green AL; Hasselblatt M; Frühwald MC; Schüller U
Acta Neuropathol; 2023 Sep; 146(3):527-541. PubMed ID: 37450044
[TBL] [Abstract][Full Text] [Related]
7. SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors.
Jeibmann A; Schulz J; Eikmeier K; Johann PD; Thiel K; Tegeder I; Ambrée O; Frühwald MC; Pfister SM; Kool M; Paulus W; Hasselblatt M
J Neurooncol; 2017 Feb; 131(3):477-484. PubMed ID: 28108836
[TBL] [Abstract][Full Text] [Related]
8. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of TEAD4 in atypical teratoid/rhabdoid tumor: New insight to the pathophysiology of an aggressive brain tumor.
Suzuki M; Kondo A; Ogino I; Arai H; Tomita T; Sredni ST
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966820
[TBL] [Abstract][Full Text] [Related]
10. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
11. Malignant brain tumor in an infant showing histopathological features of yolk sac tumor but genetic and epigenetic features of AT/RT.
Nakano Y; Satomi K; Okada K; Gotoh M; Ushiama M; Sakamoto H; Yoshida T; Kunihiro N; Hira K; Fukushima H; Inoue T; Hirato J; Ichimura K; Hara J
Pediatr Blood Cancer; 2021 Sep; 68(9):e29192. PubMed ID: 34185381
[TBL] [Abstract][Full Text] [Related]
12. An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.
Fukuoka K; Nakazawa A; Hirato J; Nobusawa S; Itabashi T; Arakawa Y; Mori M; Matsushita Y; Honda S; Tanami Y; Ichimura K; Kurihara J; Koh K
J Neuropathol Exp Neurol; 2023 Jun; 82(7):664-667. PubMed ID: 37086056
[No Abstract] [Full Text] [Related]
13. Identification of genes involved in the biology of atypical teratoid/rhabdoid tumours using Drosophila melanogaster.
Jeibmann A; Eikmeier K; Linge A; Kool M; Koos B; Schulz J; Albrecht S; Bartelheim K; Frühwald MC; Pfister SM; Paulus W; Hasselblatt M
Nat Commun; 2014 Jun; 5():4005. PubMed ID: 24892285
[TBL] [Abstract][Full Text] [Related]
14. Maternal embryonal leucine zipper kinase immunoreactivity in atypical teratoid/rhabdoid tumors: a study of 50 cases.
Ravindra N; Rao S; Arivazhagan A; Santosh V
Childs Nerv Syst; 2021 Dec; 37(12):3769-3775. PubMed ID: 34611764
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
16. Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
Paassen I; Williams J; Ríos Arceo C; Ringnalda F; Mercer KS; Buhl JL; Moreno N; Federico A; Franke NE; Kranendonk M; Upadhyaya SA; Kerl K; van de Wetering M; Clevers H; Kool M; Hoving EW; Roussel MF; Drost J
Oncogene; 2023 May; 42(20):1661-1671. PubMed ID: 37020038
[TBL] [Abstract][Full Text] [Related]
17. SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.
Hasselblatt M; Thomas C; Federico A; Nemes K; Johann PD; Bison B; Bens S; Dahlum S; Kordes U; Redlich A; Lessel L; Pajtler KW; Mawrin C; Schüller U; Nolte K; Kramm CM; Hinz F; Sahm F; Giannini C; Penkert J; Kratz CP; Pfister SM; Siebert R; Paulus W; Kool M; Frühwald MC
Am J Surg Pathol; 2022 Sep; 46(9):1277-1283. PubMed ID: 35446794
[TBL] [Abstract][Full Text] [Related]
18. Generation of a mouse model of atypical teratoid/rhabdoid tumor of the central nervous system through combined deletion of Snf5 and p53.
Ng JM; Martinez D; Marsh ED; Zhang Z; Rappaport E; Santi M; Curran T
Cancer Res; 2015 Nov; 75(21):4629-39. PubMed ID: 26363008
[TBL] [Abstract][Full Text] [Related]
19. Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
Schweizer Y; Meszaros Z; Jones DTW; Koelsche C; Boudalil M; Fiesel P; Schrimpf D; Piro RM; Brehmer S; von Deimling A; Kerl U; Seiz-Rosenhagen M; Capper D
J Neuropathol Exp Neurol; 2017 Aug; 76(8):655-664. PubMed ID: 28789476
[TBL] [Abstract][Full Text] [Related]
20. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup.
Zin F; Cotter JA; Haberler C; Dottermusch M; Neumann J; Schüller U; Schweizer L; Thomas C; Nemes K; Johann PD; Kool M; Frühwald MC; Paulus W; Judkins A; Hasselblatt M
Brain Pathol; 2021 Sep; 31(5):e12967. PubMed ID: 33938067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
